These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15617454)

  • 1. A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients.
    Ding PY; Chu KM; Chiang HT; Shu KH
    Int J Clin Pract Suppl; 2004 Dec; (145):16-22. PubMed ID: 15617454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.
    Lee YT; Lee CM; Lin CS; Sheu SH; Kuo WK; Tsai CW; Huang LC; Huang HC; Wang JS; Tseng WK
    Int J Clin Pract Suppl; 2004 Dec; (145):40-5. PubMed ID: 15617458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.
    Zhu JR; Bai J; Cai NS; Tang B; Fan WH; Guo JZ; Ke YN; Guo JX; Sheng LH; Lu ZY; Cheng NN
    Int J Clin Pract Suppl; 2004 Dec; (145):46-9. PubMed ID: 15617459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients.
    Chen JH; Cheng JJ; Chen CY; Chiou HC; Huang TY; Tsai CD; Fu MM; Cherng WJ
    Int J Clin Pract Suppl; 2004 Dec; (145):29-34. PubMed ID: 15617456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
    Smith DH; Cramer MJ; Neutel JM; Hettiarachchi R; Koval S
    Blood Press Monit; 2003 Jun; 8(3):111-7. PubMed ID: 12900588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
    Alcocer L; Fernández-Bonetti P; Campos E; Olvera Ruiz R; Bahena J; de la Fuente JJ; Segovia-Ayala C; Dominguez-Henkel R
    Int J Clin Pract Suppl; 2004 Dec; (145):35-9. PubMed ID: 15617457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of telmisartan 80 mg once daily on 24-h blood pressure profile in patients with mild-to-moderate hypertension failing to respond to prior antihypertensive therapy.
    Parra Carrillo JZ; Fernández M; Barrera M; Bahena J; Estrella M; Olivares Ruiz R; Lepe L; Arriaga R; Bonilla C; Fonseca S; Miranda S; Segovia C; García Luna Viesca MD
    Int J Clin Pract Suppl; 2004 Dec; (145):9-15. PubMed ID: 15617453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
    Alcocer L; Fernandez-Bonetti P; Campos E; Dominguez-Henkel R; de la Fuente JJ; Segovia-Ayala C
    Int J Clin Pract Suppl; 2004 Dec; (145):23-8. PubMed ID: 15617455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs.
    Neutel JM
    Blood Press Monit; 2000; 5 Suppl 1():S35-40. PubMed ID: 10904241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB; Reilly PA
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
    Minami J; Furukata S; Ishimitsu T; Matsuoka H
    Int Heart J; 2009 Jan; 50(1):85-93. PubMed ID: 19246849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.